ImmunoPrecise Antibodies Ltd (IPA)
0.3975
+0.05
(+14.09%)
USD |
NASDAQ |
Nov 22, 16:00
0.3975
0.00 (0.00%)
After-Hours: 18:13
ImmunoPrecise Antibodies Debt to Equity Ratio: 0.0791 for July 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
July 31, 2024 | 0.0791 |
April 30, 2024 | 0.00 |
January 31, 2024 | 0.00 |
October 31, 2023 | 0.00 |
July 31, 2023 | 0.00 |
April 30, 2023 | 0.00 |
January 31, 2023 | 0.00 |
October 31, 2022 | 0.00 |
July 31, 2022 | 0.00 |
April 30, 2022 | 0.0174 |
January 31, 2022 | 0.0271 |
October 31, 2021 | 0.025 |
July 31, 2021 | 0.0242 |
April 30, 2021 | 0.0269 |
January 31, 2021 | 0.0537 |
October 31, 2020 | 0.0667 |
July 31, 2020 | 0.1325 |
April 30, 2020 | 0.174 |
January 31, 2020 | 0.1934 |
October 31, 2019 | 0.1926 |
July 31, 2019 | 0.1844 |
April 30, 2019 | 0.1561 |
January 31, 2019 | 0.1383 |
October 31, 2018 | 0.1317 |
July 31, 2018 | 0.3309 |
Date | Value |
---|---|
April 30, 2018 | 0.2976 |
January 31, 2018 | 0.00 |
October 31, 2017 | 0.00 |
July 31, 2017 | 0.00 |
April 30, 2017 | 0.00 |
January 31, 2017 | 0.0241 |
September 30, 2016 | 0.1941 |
June 30, 2016 | -0.3432 |
March 31, 2016 | -0.32 |
December 31, 2015 | -0.311 |
September 30, 2015 | -0.3362 |
June 30, 2015 | -0.3551 |
March 31, 2015 | -0.3439 |
December 31, 2014 | -0.3547 |
September 30, 2014 | -0.3325 |
June 30, 2014 | -0.6602 |
March 31, 2014 | -0.7777 |
December 31, 2013 | -0.7624 |
September 30, 2013 | -0.8595 |
June 30, 2013 | -0.3512 |
March 31, 2013 | -0.3799 |
December 31, 2012 | -0.2319 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2022
0.1934
Maximum
Jan 2020
0.0432
Average
0.0242
Median
Jul 2021
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 42.81M |
Total Liabilities (Quarterly) | 19.09M |
Shareholders Equity (Quarterly) | 23.72M |
Current Ratio | 0.9862 |
Net Debt Paydown Yield | -1.74% |